Cheviot Value Management’s GSK GSK Stock Holding History

Cheviot Value Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$867	Buy	+18	New	+$919	﹤0.01%	477

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Cheviot Value Management's GSK Position: Q3 2026 in Review

Cheviot Value Management opened a new position in GSK (GSK) in Q3 2026: 18 shares worth $867. The stake represents ﹤0.01% of the portfolio and ranks #477 among its holdings.

654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Cheviot Value Management held 18 shares of GSK worth $867 as of Q3 2026.
GSK was a new Cheviot Value Management position in Q3 2026.
GSK made up ﹤0.01% of Cheviot Value Management's portfolio in Q3 2026, its #477 holding.
654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Cheviot Value Management's 13F filing for Q3 2026, filed 9 Nov 2026.